Dipyridamole-echocardiography:  clinical usefulness following interventions.
Dipyridamole-echocardiography test response can be expressed not only in a black or white (positive vs negative) code but also, in positive tests, by a gray scale integrating the severity and extent of the dyssynergy as well as the ischemia-free stress time.  The recognition of the dyssynergy is important to establish the diagnosis; however, the evaluation of the degree of the induced ischemia, stratified according to spatiotemporal coordinates, is even more important because it accurately predicts the coronary anatomical and functional situation, as well as the prognosis of the individual patient.  Furthermore, the "shades of gray" in a positive response have proved useful in assessing the beneficial effects of several interventions: coronary angioplasty; coronary artery bypass surgery; thrombolysis; and medical antianginal therapy.  Due to its excellent reproducibility, dipyridamole-echocardiography can play a pivotal role for simple, safe, fast, accurate, and objective assessment of therapeutic interventions, either mechanical or pharmacological, based upon the presence, timing, severity, and extent of dipyridamole-induced dyssynergy.
Istituto di Fisiologia Clinica, C.N.R., Pisa, Italy.
E
E
Picano
L
L
Bolognese
S
S
Pirelli
F
F
Lattanzi
G
G
Sarasso
C
C
Piccinino
F
F
Faletra
D
D
Massa
C
C
Marini
A
A
Distante
D000787:Angina Pectoris / Q000188:drug therapy; D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000628:therapy*; D004176:Dipyridamole; D004452:Echocardiography / Q000379:methods*; D006801:Humans; D015203:Reproducibility of Results; D015912:Thrombolytic Therapy; D016896:Treatment Outcome